Q3 2024 saw lower sales but a sharp rise in gross margin and a return to positive EBIT, driven by cost savings and a favorable product mix. Product development continues, with new launches expected in 2025 amid ongoing market uncertainty.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.